LBBW Venture Capital

LBBW Venture Capital (LBBW VC) is a Stuttgart-based venture capital firm founded in 1998 as an independent subsidiary of Landesbank Baden-Wurttemberg, one of Germany's largest state banks. The firm invests in early-stage disruptive IT and life science companies in the DACH region (Germany, Austria, and Switzerland), with initial ticket sizes of up to 3 million euros at seed and Series A stages. The team of seven includes two partners. Over its 18-plus-year track record the firm has invested in more than 60 companies, averaging approximately two new investments per year over the last decade. The tech team focuses on software-driven approaches within enterprise IT, IoT, Industry 4.0, AI and machine learning, and big data and analytics across industrial sectors. In life sciences, LBBW invests in drug development, diagnostics, medical devices, and healthcare IT. The firm leads rounds and has invested in 58 tracked companies. Recent investments in 2025 include Kipu Quantum (quantum computing, October 2025), Applyo-Jena (freeze-drying technology, Series A co-led with Bosch Ventures), and Blockbrain (AI-based knowledge management). The portfolio has achieved notable exits including 2 IPOs, 1 unicorn, and 11 acquisitions, with key exits including ESI Group, Oxid eSales, MTM Laboratories, and a stake sold in September 2022. Investing on behalf of LBBW enables the firm to take a long-term view on early innovation — particularly valuable for deep tech and life science companies that require patient capital through extended development cycles. LBBW VC is a member of BVK, the German Private Equity and Venture Capital Association, and leverages the parent bank's industrial and corporate relationships to open commercial doors for portfolio companies across the DACH manufacturing and technology ecosystem.